Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Verhoogd risico op pancreascarcinoom na HCV-infectie
dec 2025 | Hepatitis, Maag-darm-leveroncologie, Virale infecties